{"SLR NAME":"Association between vitamin D supplementation or serum vitamin D level and susceptibility to SARS-CoV-2 infection or COVID-19 including clinical course, morbidity and mortality outcomes? A systematic review","References":[{"title1":"
<styled-content style="fixed-case" toggle="no">COVID</styled-content>?19 in Parkinson’s Disease Patients Living in Lombardy, Italy","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","References":[]},{"title2":"Impact of the COVID-19 pandemic on Parkinson's disease and movement disorders","References":[]},{"title2":"Neurological complications of coronavirus disease (COVID-19): encephalopathy","References":[{"title3":"Neurological complications of coronavirus disease (COVID-19): encephalopathy"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"COVID 19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features [Epub ahead of print]"},{"title3":"Neurologic complications of coronavirus infections [Epub ahead of print]"},{"title3":"Neurologic manifestations of severe respiratory viral contagions"}]},{"title2":"Outcome of Parkinson's disease patients affected by COVID-19","References":[{"title3":"Drooling in Parkinson's disease: prevalence and progression from the Non-motor International Longitudinal Study"},{"title3":"Parkinson's disease and COVID-19: perceptions and implications in patients and caregivers"},{"title3":"The Impact of the COVID-19 pandemic on Parkinson's disease: hidden sorrows and emerging opportunities"},{"title3":"Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease"},{"title3":"Angiotensin type 2 receptors: role in aging and neuroinflammation in the substantia nigra"},{"title3":"The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease"},{"title3":"a new nosological entity"},{"title3":"An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19"},{"title3":"Management of advanced therapies in Parkinson's disease patients in times of humanitarian crisis: the COVID-19 experience"}]},{"title2":"Parkinson's disease and COVID-19: perceptions and implications in patients and caregivers","References":[{"title3":"The impact of the COVID-19 pandemic on Parkinson's disease: hidden sorrows and emerging opportunities"},{"title3":"Editorial: movement disorders in the world of COVID-19"},{"title3":"Impact of the COVID-19 pandemic on Parkinson's disease and movement disorders"}]},{"title2":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region","References":[]},{"title2":"  . COVID-19 Italia:Monitoraggio della situazione [online]. Available at: http://opendatadpc.maps.arcgis.com/apps/opsdashboard/index.html#/b0c68bce2cce478eaac82fe38d4138b1.","References":[]},{"title2":"MDS clinical diagnostic criteria for Parkinson's disease","References":[{"title3":"Pharmacological treatment of Parkinson disease: a review"},{"title3":"The prevalence of Parkinson's disease: a systematic review and meta-analysis"},{"title3":"Staging of brain pathology related to sporadic Parkinson's disease"},{"title3":"Parkinson disease"},{"title3":"Parkinson's disease"},{"title3":"MDS clinical diagnostic criteria for Parkinson's disease"},{"title3":"The genetic background of Parkinson's disease: current progress and future prospects"},{"title3":"Parkinson's disease: from monogenic forms to genetic susceptibility factors"},{"title3":"The genetics of Parkinson disease"},{"title3":"Association between early-onset Parkinson's disease and mutations in the parkin gene"},{"title3":"Characterization of PLA2G6 as a locus for dystonia-parkinsonism"},{"title3":"Genetic analysis of ATP13A2, PLA2G6 and FBXO7 in a cohort of Chinese patients with early-onset Parkinson's disease"},{"title3":"Novel compound heterozygous PRKN variants in a Han-Chinese family with early-onset Parkinson's disease"},{"title3":"Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27"},{"title3":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism"},{"title3":"Mutation analysis of PARK2 in a Uyghur family with early-onset Parkinson's disease in Xinjiang, China"},{"title3":"Han Chinese family with early-onset Parkinson's disease carries novel compound heterozygous mutations in the PARK2 gene"},{"title3":"Complex relationship between Parkin mutations and Parkinson disease"},{"title3":"PARK2 mutations and clinical features in a Chinese population with early-onset Parkinson's disease"},{"title3":"PRKN, DJ-1, and PINK1 screening identifies novel splice site mutation in PRKN and two novel DJ-1 mutations"},{"title3":"The role of genetics in Parkinson's disease: a large cohort study in Chinese mainland population"},{"title3":"Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase"},{"title3":"How much phenotypic variation can be attributed to parkin genotype?"},{"title3":"Phenotype analysis in patients with early onset Parkinson's disease with and without parkin mutations"},{"title3":"Isolated limb dystonia as presenting feature of Parkin disease"},{"title3":"Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?"},{"title3":"Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease"},{"title3":"Cognitive and motor function in long-duration PARKIN-associated Parkinson disease"},{"title3":"Early Onset Parkinson's disease due to DJ1 mutations: an Indian study"},{"title3":"Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism"},{"title3":"PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson's disease"},{"title3":"PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort"},{"title3":"Homozygous p.D331Y mutation in PLA2G6 in two patients with pure autosomal-recessive early-onset parkinsonism: further evidence of a fourth phenotype of PLA2G6-associated neurodegeneration"},{"title3":"Missense mutations in TENM4, a regulator of axon guidance and central myelination, cause essential tremor"},{"title3":"Genetic testing of FUS, HTRA2, and TENM4 genes in Chinese patients with essential tremor"},{"title3":"Essential tremor linked TENM4 mutation found in healthy Chinese individuals"},{"title3":"Exome sequencing identifies as a novel candidate gene for schizophrenia in the SCZD2 locus at 11q14-21"}]},{"title2":"Considerations for obesity, vitamin D, and physical activity amidst the COVID-19 pandemic","References":[]},{"title2":"COVID-19 and vitamin D-Is there a link and an opportunity for intervention?","References":[{"title3":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status"},{"title3":"Association of vitamin D supplementation with respiratory tract infection in infants"},{"title3":"Identification of amitriptyline HCl, flavin adenine dinucleotide, azacitidine and calcitriol as repurposing drugs for influenza A H5N1 virus-induced lung injury"},{"title3":"VDR rs2228570 polymorphism is related to non-progression to AIDS in antiretroviral therapy naive HIV-infected patients"},{"title3":"Vitamin D in human immunodeficiency virus infection: influence on immunity and disease"},{"title3":"Vitamin D receptor genotype influences risk of upper respiratory infection"},{"title3":"The interplay between vitamin D and viral infections"},{"title3":"Pulmonary activation of vitamin D3 and preventive effect against interstitial pneumonia"},{"title3":"Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system"},{"title3":"The association between vitamin D deficiency and community-acquired pneumonia: A meta-analysis of observational studies"}]},{"title2":"Enhancing immunity in viral infections, with special emphasis on COVID-19: a review","References":[{"title3":"Enhancing immunity in viral infections, with special emphasis on COVID-19: a review"},{"title3":"Gut microbiota and COVID-19- possible link and implications [published online ahead of print, 2020 May 13]"},{"title3":"Microbiological results of improvement in periodontal condition by administration of oral Probiotics"},{"title3":"Focus on receptors for coronaviruses with special reference to angiotensin-converting enzyme 2 as a potential drug target - a perspective"},{"title3":"[The intestinal virobiota, a new component in the interactions between the microbiota and the immune system]"}]},{"title2":"A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Viral metagenomics revealed Sendai virus and coronavirus infection of Malayan pangolins (Manis javanica)"},{"title3":"Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak"},{"title3":"On the origin and continuing evolution of SARS-CoV-2"},{"title3":"Conjunctival polymerase chain reaction-tests of 2019 novel coronavirus in patients in Shenyang, China"},{"title3":"Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient"},{"title3":"Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents"},{"title3":"Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination"},{"title3":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1"},{"title3":"Understanding the symptoms of the common cold and influenza"},{"title3":"Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19)"},{"title3":"Preliminary clinical description of severe acute respiratory syndrome"},{"title3":"MERS clinical features"},{"title3":"Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1)"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Novel coronavirus (COVID-19) situation"},{"title3":"Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China"},{"title3":"Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures"},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission"},{"title3":"Coronavirus COVID-19 global cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)"},{"title3":"Clinical management of severe acute respiratory infection when COVID-19 is suspected: interim guidance"},{"title3":"Evaluating and testing persons for coronavirus disease 2019 (COVID-19)"},{"title3":"Correlation of chest CT and RT-PCR testing in Coronavirus Disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records"},{"title3":"Discharge criteria for confirmed COVID-19 cases - When is it safe to discharge COVID-19 cases from the hospital or end home isolation?"},{"title3":"Updated IPAC recommendations for use of personal protective equipment for care of individuals with suspect or confirmed COVID-19"},{"title3":"Beneficial effects of ascorbic acid to treat lung fibrosis induced by paraquat"},{"title3":"Neutrophil extracellular traps are elevated in patients with pneumonia-related acute respiratory distress syndrome"},{"title3":"The emerging role of vitamin C as a treatment for sepsis"},{"title3":"Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)"},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19"},{"title3":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"},{"title3":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors"},{"title3":"Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats"},{"title3":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Critically ill patients with the Middle East respiratory syndrome: a multicenter retrospective cohort study"}]},{"title2":"Does vitamin D status impact mortality from SARS-CoV-2 infection?","References":[{"title3":"Is vitamin D deficiency a major global health problem"},{"title3":"Worldwide vitamin D status"},{"title3":"Aging decreases the capacity of human skin to produce Vitamin D3"},{"title3":"Vitamin D status among older adults residing in Littoral and Andes Mountains in Ecuador"},{"title3":"Immunomodulatory effects of Vitamin D in influenza infection"},{"title3":"Calcitriol [1, 25[OH]2 D3] pre- and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells"},{"title3":"The effect of inflammatory cytokines and the level of vitamin D on prognosis in Crimean-Congo hemorrhagic fever"},{"title3":"Vitamin D deficiency conributes directly to the acute respiratory distress syndrome (ARDS)"},{"title3":"Vitamin D deficiency and acute lung injury"},{"title3":"Vitamin D status has a linear association with seasonal infections and lung function in British adults"},{"title3":"Epidemic influenza and vitamin D"},{"title3":"Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey"},{"title3":"Vitamin D and respiartory tract infections: A systematic review and meta-analysis of randomized controlled trials"},{"title3":"The possible roles of solar ulraviolet-B radiation and vitamin D in reducing case fatality rates from the 1918-1919 influenza pandemic in the United States"},{"title3":"Editorial: low population mortality from COVID-19 in countries south of 35 degrees North - supports vitamin D as a factor determining severity"},{"title3":"The role of vitamin D in suppressing cytokine storm of COVID-19 patients and associated mortality"}]},{"title2":"Optimisation of vitamin D status for enhanced immuno-protection against Covid-19","References":[]},{"title2":"Vitamin D: a simpler alternative to tocilizumab for trial in COVID-19?","References":[{"title3":"WHO Coronavirus disease 2019 (COVID-19) situation report - 66. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200326-sitrep-66-covid-19.pdf?sfvrsn=81b94e61_2. Published March 26, 2020. Accessed March 27, 2020."},{"title3":"Gianotti G. I'm a doctor at Italy's hardest-hit hospital. I had to decide who got a ventilator and who didn't. https://www.abc.net.au/news/2020-03-27/coronavirus-doctor-cremona-hospital-decide-who-lives-and-dies/1209091Published March 27, 2020. Accessed March 27, 2020."},{"title3":"Chinese Clinical Trial Registry: A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19). http://www.chictr.org.cn/showprojen.aspx?proj=49409."},{"title3":"ClinicalTrials.gov: Tocilizumab in COVID-19 Pneumonia (TOCIVID-19). https://www.clinicaltrials.gov/ct2/show/NCT04317092."},{"title3":"Conti P, Ronconi G, Caraffa A, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020 Mar 14;34(2). pii: 1. doi: 10.23812/CONTI-E. [Epub ahead of print]."},{"title3":"Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295. Published 2014 Sep 4. doi: 10.1101/cshperspect.a016295."},{"title3":"A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy"},{"title3":"The role of season in the epidemiology of influenza"},{"title3":"Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren"},{"title3":"Vitamin D deficiency is associated with IL-6 levels and monocyte activation in HIV-infected persons"},{"title3":"The cytokine storm of severe influenza and development of immunomodulatory therapy"},{"title3":"Role of vitamin D3 in regulation of interleukin-6 and osteopontin expression in liver of diabetic mice"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Sex difference and smoking predisposition in patients with COVID-19"},{"title3":"Analysis of 25-hydroxyvitamin D status according to age, gender, and seasonal variation"},{"title3":"Prevalence of vitamin D inadequacy among Chinese postmenopausal women: a nationwide, multicenter, cross-sectional study"}]},{"title2":"The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality","References":[{"title3":"Peeri NC, Shrestha N, Rahman S et al (2020) The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 10.1093/ije/dyaa033"},{"title3":"Bohning D, Rocchetti I, Maruotti A, and Holling H (2020) Estimating the undetected infections in the Covid-19 outbreak by harnessing capture-recapture methods. Int J Infect Dis. 10.1016/j.ijid.2020.06.009"},{"title3":"Giordano G, Blanchini F, Bruno R, Colaneri P, Di Filippo A, Di Matteo A, Colaneri M (2020) Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. Nat Med 26:855-860. 10.1038/s41591-020-0883-7"},{"title3":"Giorgi PD, Schiro GR, Capitani D, D'Aliberti G, Gallazzi E (2020) Vertebral compression fractures in multiple myeloma: redefining the priorities during the COVID-19 pandemic. Aging Clin Exp Res. 10.1007/s40520-020-01590-4"},{"title3":"Nanda A, Vura NVRK, Gravenstein S (2020) COVID-19 in older adults. Aging Clin Exp Res. 10.1007/s40520-020-01581-5"},{"title3":"Onder G, Rezza G, Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 323:1775-1776. 10.1001/jama.2020.4683"},{"title3":"Tuite AR, Ng V, Rees E et al (2020) Estimation of COVID-19 outbreak size in Italy. Lancet Infect Dis 20:537. 10.1016/S1473-3099(20)30227-9  "},{"title3":"(2020) COVID-19: the medium is the message"},{"title3":"Limaye RJ, Sauer M, Ali J et al (2020) Building trust while influencing online COVID-19 content in the social media world. Lancet Digit Health 2:e277-e278"},{"title3":"Epidemic influenza and vitamin D"},{"title3":"Vitamin D and influenza-prevention or therapy?"},{"title3":"Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials"},{"title3":"Vitamin D for prevention of respiratory tract infections: a systematic review and meta-analysis"},{"title3":"Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data"},{"title3":"Ilie PC, Stefanescu S, Smith L (2020) The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 10.1007/s40520-020-01570-8"},{"title3":"Correlations genuine and spurious in Pearson and Yule"},{"title3":"Vigen T (2015) Spurious correlations. Hachette Books ISBN: 9780316339438"},{"title3":"On a form of spurious correlation which may arise when indices are used in the measurement of organs"},{"title3":"On the mathematical theory of errors of judgment, with special reference to the personal equation"},{"title3":"A critical evaluation of the current &quot;p-value&quot; controversy"}]},{"title2":"25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis"},{"title3":"A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19)"},{"title3":"Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths"},{"title3":"Optimisation of Vitamin D Status for Enhanced Immuno-protection Against Covid-19"},{"title3":"Vitamin D, Covid-19 and Children"},{"title3":"Letter: Covid-19, and vitamin D"},{"title3":"Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory Bowel Disease"}]},{"title2":"Risk factors of critical &amp; mortal COVID-19 cases: a systematic literature review and meta-analysis","References":[]},{"title2":"An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19","References":[{"title3":"The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients"},{"title3":"Mining for coexpression across hundreds of datasets using novel rank aggregation and visualization methods"},{"title3":"The differential effect of angiotensin II and angiotensin 1-7 on norepinephrine, epinephrine, and dopamine concentrations in rat hypothalamus: the involvement of angiotensin receptors"},{"title3":"Kidney dopamine D1-like receptors and angiotensin 1-7 interaction inhibits renal Na+ transporters"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Depletion of angiotensin-converting enzyme 2 reduces brain serotonin and impairs the running-induced neurogenic response"},{"title3":"Peripheral dopamine controlled by gut microbes inhibits invariant natural killer T cell-mediated hepatitis"},{"title3":"Frontline science: D1 dopaminergic receptor signaling activates the AMPK-bioenergetic pathway in macrophages and alveolar epithelial cells and reduces endotoxin-induced ALI"},{"title3":"Age-related dopaminergic innervation augments T helper 2-type allergic inflammation in the postnatal lung"},{"title3":"Emerging role of l-dopa decarboxylase in flaviviridae virus infections"}]},{"title2":"A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing","References":[]},{"title2":"Amantadine disrupts lysosomal gene expression; potential therapy for COVID19","References":[{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2"},{"title3":"Nextstrain: real-time tracking of pathogen evolution"},{"title3":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor"},{"title3":"The Genotype-Tissue Expression (GTEx) project"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry"},{"title3":"Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors' CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design"},{"title3":"Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases"},{"title3":"Influenza"},{"title3":"Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A"},{"title3":"Identification of the functional core of the influenza A virus A/M2 proton-selective ion channel"},{"title3":"Lysosomotropic Drugs: Pharmacological Tools to Study Lysosomal Function"},{"title3":"The location of amantadine hydrochloride and free base within phospholipid multilayers: a neutron and X-ray diffraction study"},{"title3":"Bioavailability and Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets in Healthy Volunteers: Results from Three Randomized, Crossover, Open-Label, Phase 1 Studies"},{"title3":"The BioMart community portal: an innovative alternative to large, centralized data repositories"},{"title3":"Genes and environment: novel, functional polymorphism in the human cathepsin L (CTSL1) promoter disrupts a xenobiotic response element (XRE) to alter transcription and blood pressure"},{"title3":"Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes"},{"title3":"COVID-19: faecal-oral transmission?"},{"title3":"Genetic diseases conferring resistance to infectious diseases"},{"title3":"Chinese hamster ovary cell lines selected for resistance to ebolavirus glycoprotein mediated infection are defective for NPC1 expression"},{"title3":"Niemann-Pick C1 Heterogeneity of Bat Cells Controls Filovirus Tropism"},{"title3":"Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia"}]},{"title2":"Conductance and amantadine binding of a pore formed by a lysine-flanked transmembrane domain of SARS coronavirus envelope protein","References":[]},{"title2":"Inhibitors of the renin-angiotensin-aldosterone system and Covid-19","References":[{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"ACEI/ARB use and risk of infection or severity or mortality of COVID-19: a systematic review and meta-analysis"},{"title3":"Decreased mortality of COVID-19 with renin-angiotensin-aldosterone system inhibitors therapy in patients with hypertension: a meta-analysis"},{"title3":"A meta-analysis of the relationship between renin-angiotensin-aldosterone system inhibitors and COVID-19"},{"title3":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study"},{"title3":"A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers"},{"title3":"The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis"},{"title3":"Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis"},{"title3":"Outcomes of renin-angiotensin-aldosterone system blockers in patients with COVID-19: a systematic review and meta-analysis"},{"title3":"Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in patients with COVID-19: a rapid systematic review and meta-analysis"},{"title3":"Renin-angiotensin system antagonists are associated with lower mortality in hypertensive patients with COVID-19"},{"title3":"Effect of renin-angiotensin-aldosterone system inhibitors in patients with COVID-19: a systematic review and meta-analysis of 28,872 patients"},{"title3":"Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: systematic review and meta-analysis"},{"title3":"Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis"},{"title3":"Renin-angiotensin system inhibitors and COVID-19: a systematic review and meta-analysis. Evidence for significant geographical disparities"},{"title3":"Mortality and disease severity among COVID-19 patients receiving renin-angiotensin system inhibitors: a systematic review and meta-analysis"},{"title3":"Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis"},{"title3":"A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: what is the evidence so far?"},{"title3":"The effect of prior ACEI/ARB treatment on COVID-19 susceptibility and outcome: a systematic review and meta-analysis"},{"title3":"Severe acute respiratory syndrome coronavirus 2 and renin-angiotensin system blockers: a review and pooled analysis"},{"title3":"The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: a systematic review and meta-analysis"},{"title3":"Lack of association of antihypertensive drugs with the risk and severity of COVID-19: a meta-analysis"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis"},{"title3":"Angiotensin converting enzyme inhibitors and angiotensin receptor blockers and mortality among COVID-19 patients: a systematic review and meta-analysis"},{"title3":"Comparison of infection risks and clinical outcomes in patients with and without SARS-CoV-2 lung infection under renin-angiotensin-aldosterone system blockade: systematic review and meta-analysis"},{"title3":"Effects of renin-angiotensin-aldosterone system inhibitors on disease severity and mortality in patients with COVID-19: a meta-analysis"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on in-hospital mortality in COVID-19 patients: a systematic review and meta-analysis"},{"title3":"Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes fromCoViD-19: systematic review and meta-analysis"},{"title3":"Renin-angiotensin system blocker and outcomes of COVID-19: a systematic review and meta-analysis"},{"title3":"Mortality, severity, and hospital admission among COVID-19 patients with ACEI/ARB use: a meta-analysis stratifying countries based on response to the first wave of the pandemic"},{"title3":"Clinical outcome of renin-angiotensin-aldosterone system blockers in treatment of hypertensive patients with COVID-19: a systematic review and meta-analysis"},{"title3":"Renin-angiotensin-aldosterone system inhibitors and COVID-19: a meta-analysis and systematic review"},{"title3":"Association between renin-angiotensin-aldosterone system inhibitors and clinical outcomes in patients with COVID-19: a systematic review and meta-analysis"},{"title3":"Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis"},{"title3":"Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors in COVID-19: meta-analysis/meta-regression adjusted for confounding factors"},{"title3":"Does taking an angiotensin inhibitor increase the risk for COVID-19? A systematic review and meta-analysis"},{"title3":"Associations between the use of renin-angiotensin system inhibitors and the risks of severe COVID-19 and mortality in COVID-19 patients with hypertension: a meta-analysis of observational studies"},{"title3":"Chronic use of renin-angiotensin-aldosterone inhibitors in hypertensive COVID-19 patients: results from a Spanish registry and meta-analysis"},{"title3":"Renin-angiotensin-aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis"},{"title3":"Renin-angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials"},{"title3":"Safety and efficacy of renin-angiotensin-aldosterone system inhibitors in COVID-19 population"},{"title3":"Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and meta-analysis"},{"title3":"Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all-cause mortality and other clinical outcomes in patients with confirmed COVID-19: a systemic review and meta-analysis"},{"title3":"Meta-analysis of the association between angiotensin pathway inhibitors and COVID-19 severity and mortality"},{"title3":"The effect of chronic and inhospital exposure to renin-angiotensin system inhibitors on the outcome and inflammatory state of coronavirus disease 2019 adult inpatients"},{"title3":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry"},{"title3":"Comparing the binding interactions in the receptor binding domains of SARS-CoV-2 and SARS-CoV"},{"title3":"Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system"},{"title3":"Counter-regulatory renin-angiotensin system in cardiovascular disease"},{"title3":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway"},{"title3":"Entry of human coronavirus NL63 into the cell"},{"title3":"SARS-CoV-2 infects cells following viral entry via clathrin-mediated endocytosis"},{"title3":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2"},{"title3":"In-vivo and in-vitro conversion of angiotensin I to angiotensin II in dog blood"},{"title3":"Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century"},{"title3":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro"},{"title3":"Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial"},{"title3":"Effect of hydroxychloroquine in hospitalized patients with Covid-19"},{"title3":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency"},{"title3":"Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies"},{"title3":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection"},{"title3":"Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19"},{"title3":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro"},{"title3":"In COVID-19, adding lopinavir-ritonavir to usual care did not shorten time to clinical improvement"},{"title3":"Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement"},{"title3":"Remdesivir for treatment of COVID-19: an updated systematic review and meta-analysis"},{"title3":"Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis of randomized controlled trials"},{"title3":"Remdesivir therapy in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials"},{"title3":"Remdesivir for adults with COVID-19: a living systematic review for American College of Physicians Practice Points"},{"title3":"Major update: remdesivir for adults with COVID-19: a living systematic review and meta-analysis for the American College of Physicians Practice Points"},{"title3":"Clinical outcomes and plasma concentrations of baloxavir marboxil and favipiravir in COVID-19 patients: an exploratory randomized, controlled trial"},{"title3":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro"},{"title3":"Use of ivermectin is associated with lower mortality in hospitalized patients with coronavirus disease 2019: the ivermectin in COVID nineteen study"},{"title3":"Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia"},{"title3":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice"},{"title3":"Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets"},{"title3":"SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801"},{"title3":"Molnupiravir inhibits replication of the emerging SARS-CoV-2 variants of concern in a hamster infection model"},{"title3":"Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients"},{"title3":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19"},{"title3":"Covid-19: Pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports"},{"title3":"Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection"},{"title3":"Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors"},{"title3":"Potential protease inhibitors and their combinations to block SARS-CoV-2"},{"title3":"SARS: epidemiology"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Functional pathophysiology of SARS-CoV-2 induced acute lung injury and clinical implications"},{"title3":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19"},{"title3":"Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury"},{"title3":"Chronic hypoxia impairs pulmonary venous smooth muscle contraction"},{"title3":"Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases"},{"title3":"Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease"},{"title3":"A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology"},{"title3":"Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic"},{"title3":"Acute myocarditis as the main clinical manifestation of SARS-CoV 2 infection"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications"},{"title3":"COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation"},{"title3":"Angiotensin II tissue factor and the thrombotic paradox of hypertension"},{"title3":"Prothrombotic effects of angiotensin"},{"title3":"The cytokine storm and COVID-19"},{"title3":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China"},{"title3":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?"},{"title3":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease"},{"title3":"Angiotensin II and gene expression in the kidney"},{"title3":"Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy"},{"title3":"Angiotensin II modulates salty and sweet taste sensitivities"},{"title3":"The neuronal role of angiotensin II in thirst, sodium appetite, cognition and memory"},{"title3":"Brain renin-angiotensin system and microglial polarization: implications for aging and neurodegeneration"},{"title3":"The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings"},{"title3":"COVID-19, de novo seizures, and epilepsy: a systematic review"},{"title3":"Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy"},{"title3":"Angiotensin II blocks hippocampal long-term potentiation"},{"title3":"The roles of genetic factors in kawasaki disease: a systematic review and meta-analysis of genetic association studies"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Telmisartan for treatment of Covid-19 patients: an open multicenter randomized clinical trial"},{"title3":"The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses"},{"title3":"Evidence based medicine: what it is and what it isn't"},{"title3":"Progress in evidence-based medicine: a quarter century on"},{"title3":"WHO-Europe. Evidence-informed policy-making. Available from: https://www.euro.who.int/en/data-and-evidence/evidence-informed-policy-making/about-us [accessed 15.02.21]."}]},{"title2":"Non-steroidal anti-inflammatory drugs and covid-19","References":[{"title3":"2015 esc guidelines for the diagnosis and management of pericardial diseases: The task force for the management of infective endocarditis of the European society of cardiology (ESC): Endorsed by: European association for cardio-thoracic surgery (EACTS)"},{"title3":"COVID-19 pandemic in resource-poor countries: Challenges, experiences and opportunities in Ghana"},{"title3":"Surviving sepsis campaign: Guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)"},{"title3":"Post-COVID-19 pneumonia lung fibrosis: A worrisome sequelae in surviving patients"},{"title3":"Indomethacin has a potent antiviral activity against SARS coronavirus"},{"title3":"One year after first case of COVID-19 in Ghana: Epidemiology, challenges and accomplishments"},{"title3":"Possible future trajectory of COVID-19: Emphasis on africa"},{"title3":"Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: The REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial"},{"title3":"Use of nonsteroidal antiinflammatory drugs: An update for clinicians: A scientific statement from the American heart association"},{"title3":"Efficacy of naproxen in the management of patients hospitalized with COVID-19 infection: A randomized, double-blind, placebo-controlled, clinical trial"},{"title3":"Is acetylsalicylic acid a safe and potentially useful choice for adult patients with COVID-19"},{"title3":"Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: The AIRTRIP randomized clinical trial"},{"title3":"Risk of cardiovascular events and celecoxib: A systematic review and meta-analysis"},{"title3":"Corticosteroids in COVID-19 and non-COVID-19 ARDS: A systematic review and meta-analysis"},{"title3":"Nonsteroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection"},{"title3":"Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019"},{"title3":"COVID-19 myopericarditis: It should be kept in mind in today's conditions"},{"title3":"Dexamethasone in hospitalised COVID-19 patients not on intensive respiratory support"},{"title3":"Cardiac tamponade secondary to COVID-19"},{"title3":"The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?"},{"title3":"Fusing visual and clinical information for lung tissue classification in high-resolution computed tomography"},{"title3":"Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: A randomized clinical trial"},{"title3":"COVID-19 and venous thromboembolism: A meta-analysis of literature studies"},{"title3":"From naproxen repurposing to naproxen analogues and their antiviral activity against influenza A virus"},{"title3":"Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: Results from a randomised controlled clinical trial"},{"title3":"Identification and in vivo efficacy assessment of approved orally bioavailable human host protein-targeting drugs with broad anti-influenza A activity"},{"title3":"Steroids: Pharmacology, complications, and practice delivery issues"},{"title3":"Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-covid): A UK multicentre, prospective cohort study"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Misguided drug advice for COVID-19"},{"title3":"Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19"},{"title3":"Corticosteroids for COVID-19 therapy: Potential implications on tuberculosis"},{"title3":"Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness"},{"title3":"Biological subphenotypes of acute respiratory distress syndrome may not reflect differences in alveolar inflammation"},{"title3":"Celebrex adjuvant therapy on coronavirus disease 2019: An experimental study"},{"title3":"Effect of dexamethasone in hospitalized patients with COVID-19 - preliminary report"},{"title3":"Selective COX-2 inhibitors, NSAIDs and cardiovascular events - is celecoxib the safest choice?"},{"title3":"Characteristics of SARS-CoV-2 and COVID-19"},{"title3":"Mast cell-induced lung injury in mice infected with H5N1 influenza virus"},{"title3":"Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19"},{"title3":"Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection: An open-label randomized, controlled, phase IIb/III trial"},{"title3":"A long-term study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthritis"},{"title3":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia"},{"title3":"Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: Safety and potentiality"},{"title3":"Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management"},{"title3":"Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes"},{"title3":" In vitro assessment of the antiviral activity of ketotifen, indomethacin and naproxen, alone and in combination, against sars-cov-2"},{"title3":"NF-kappaB pathway as a potential target for treatment of critical stage COVID-19 patients"},{"title3":"Mucormycosis in COVID-19 recovered patients"},{"title3":"The use of non-steroidal anti-inflammatory drugs (NSAIDs) in COVID-19"},{"title3":"Severe acute respiratory syndrome: Clinical and laboratory manifestations"},{"title3":"Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza a virus"},{"title3":"Longitudinal cytokine profile in patients with mild to critical COVID-19"},{"title3":"Effectiveness of covid-19 vaccines against the B.1.617.2 (delta) variant"},{"title3":"Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study"},{"title3":"Sino-orbital mucormycosis in a COVID-19 patient: A case report"},{"title3":"Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome"},{"title3":"Pros and cons of corticosteroid therapy for COVID-19 patients"},{"title3":"NSAIDs and COVID-19: A systematic review and meta-analysis"},{"title3":"Ketotifen in prevention of indomethacin-induced gastropathy"},{"title3":"Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO clinical characterisation protocol UK: Prospective, cohort study"},{"title3":"COVID-19) treatment guidelines"},{"title3":"Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic"},{"title3":"Response to the novel corona virus (COVID-19) pandemic across africa: Successes, challenges, and implications for the future"},{"title3":"Pulmonary fibrosis in COVID-19 survivors: Predictive factors and risk reduction strategies"},{"title3":"Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?"},{"title3":"COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment"},{"title3":"TMPRSS2: An equally important protease as ACE2 in the pathogenicity of SARS-CoV-2 infection"},{"title3":"COVID-19 and NSAIDS: A narrative review of knowns and unknowns"},{"title3":"Identifying clinical and biochemical phenotypes in acute respiratory distress syndrome secondary to coronavirus disease-2019"},{"title3":"Ibuprofen use and clinical outcomes in COVID-19 patients"},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia"},{"title3":"Safety of ibuprofen in patients with COVID-19: Causal or confounded?"},{"title3":"Use of aspirin in reduction of mortality of COVID-19 patients: A meta-analysis"},{"title3":"Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage"},{"title3":"Indomethacin treatment of human adult respiratory distress syndrome"},{"title3":"The hallmarks of COVID-19 disease"},{"title3":"Structure-based design of novel naproxen derivatives targeting monomeric nucleoprotein of Influenza A virus"},{"title3":"Use of steroids in COVID-19 patients: A meta-analysis"},{"title3":"Warning against the use of anti-inflammatory Medicines to cure COVID-19: Building castles in the air"},{"title3":"Adjunctive glucocorticoid therapy in patients with septic shock"},{"title3":"Risks associated with the use of non-steroidal anti-inflammatory drugs during pneumonia"},{"title3":"Systemic corticosteroids for the treatment of COVID-19"},{"title3":"Acute respiratory infection and use of nonsteroidal anti-inflammatory drugs on risk of acute myocardial infarction: A nationwide case-crossover study"},{"title3":"Cox-1 and Cox-2 products in the gut: Therapeutic impact of Cox-2 inhibitors"},{"title3":"The use of Janus Kinase inhibitors in hospitalized patients with COVID-19: Systematic review and meta-analysis"},{"title3":"The therapeutic effectiveness of ibuprofen on the symptoms of naturally acquired common colds"},{"title3":"Potential benefits of ibuprofen in the treatment of viral respiratory infections"},{"title3":"Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: An OpenSAFELY cohort analysis based on two cohorts"},{"title3":"Epidemiological update on COVID-19"},{"title3":"COVID-19: Immunopathogenesis and immunotherapeutics"},{"title3":"Zoonotic origins of human coronaviruses"},{"title3":"The use of methylprednisolone in COVID-19 patients: A propensity score matched retrospective cohort study"},{"title3":"Ketotifen is protective against indomethacin-induced intestinal ulceration in the rat"},{"title3":"ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities"},{"title3":"Selective COX-2 inhibitors: A review of their structure-activity relationships"},{"title3":"Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19 (metcovid): A randomised, double-blind, phase IIb, placebo-controlled trial"},{"title3":"The use of non-steroidal anti-inflammatory drugs for coronavirus disease 2019: Adjunct therapy"},{"title3":"Naproxen exhibits broad anti-influenza virus activity in mice by impeding viral nucleoprotein nuclear export"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, China: A retrospective cohort study"},{"title3":"Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis"},{"title3":"The novel coronavirus outbreak in Wuhan, China"}]},{"title2":"The impact of the COVID-19 pandemic on Parkinson's disease: hidden sorrows and emerging opportunities","References":[{"title3":"The impact of the COVID-19 pandemic on Parkinson's disease: Hidden sorrows and emerging opportunities"},{"title3":"Caregiver burden in Parkinson disease: A critical review of recent literature"}]},{"title2":"Management of advanced therapies in Parkinson's disease patients in times of humanitarian crisis: the COVID-19 experience","References":[]},{"title2":"The effect of levodopa on pulmonary function in Parkinson's disease: a systematic review and meta-analysis","References":[]},{"title2":"Dyspnea: an underestimated symptom in Parkinson's disease","References":[]},{"title2":"Ventilatory dysfunction in Parkinson's disease","References":[]},{"title2":"Levodopa-induced respiratory dysfunction confirmed by levodopa challenge test: a case report","References":[{"title3":"Non-motor symptoms in Parkinson's disease"},{"title3":"Respiratory dysfunction in Parkinson's disease"},{"title3":"Non-motor symptoms in Parkinson's disease"},{"title3":"Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: results of a levodopa challenge test"},{"title3":"Pulmonary function in Parkinson's disease"},{"title3":"Effects of levodopa on pulmonary function in Parkinson's disease"},{"title3":"L-dopa-induced respiratory disturbance in Parkinson's disease suppressed by tiapride"},{"title3":"Causes of death in a community-based study of Parkinson's disease"},{"title3":"Pearls in patient selection for deep brain stimulation"}]},{"title2":"The invisible hand:medical care during the pandemic","References":[]},{"title2":"The coronavirus and the risks to the elderly in long-term care","References":[]},{"title2":"Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths","References":[{"title3":"Evidence that vitamin D supplementation could reduce risk of influenza and covid-19 infections and deaths"},{"title3":"Effect of vitamin D3 supplementation on respiratory tract infections in healthy individuals: A systematic review and meta-analysis of randomized controlled trials"},{"title3":"Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data"},{"title3":"Monthly high-dose vitamin D supplementation does not increase kidney stone risk or serum calcium: Results from a randomized controlled trial"},{"title3":"Effect of high-dose vitamin D supplementation on volumetric bone density and bone strength: a randomized clinical trial"},{"title3":"Clinical Trial [Trial No: IRCT20200324046850N1]"},{"title3":"Clnical Trial [Trial No: ChiCTR2000031163]"}]}]},{"title1":"25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2","References":[{"title2":"Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"WHO main website. https://www.who.int(accessed March 2, 2020)."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"National Health Commission of the People's Republic of China. http://www.nhc.gov.cn(Assessed on March 2, 2020)."},{"title3":"Sun P, Qie S, Liu Z, et al. Clinical characteristics of hospitalized patientswith SARS-CoV-2 infection: a single arm meta-analysis. J Med Virol 2020. doi:10.1002/jmv.25735."},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury"},{"title3":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined chinese and western medicine treatment"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province"},{"title3":"Chung M, Bernheim A. CT Imaging Features of 2019 Novel Coronavirus(2019-nCoV). Radiology 2020 Apr;295(1):202-207."},{"title3":"Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, ofnovel coronavirus-infected pneumonia. N Engl J Med 2020.doi: 10.1056/NEJMoa2001316."},{"title3":"Song F, Shi N, Shan F, et al. Emerging 2019 Novel Coronavirus(2019-nCoV) Pneumonia. Radiology 2020:200274."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Pan Y, Guan H, Zhou S, et al. Initial CT findings and temporal changes inpatients with the novel coronavirus pneumonia (2019-nCoV): a study of 63patients in Wuhan, China. Eur Radiol 2020.doi: 10.1007/s00330-020-06731-x."},{"title3":"Pan F, Ye T. Time course of lung changes on chest CT during recovery from2019 novel coronavirus (COVID-19) pneumonia. Radiology 2020:200370.doi: 10.1148/radiol.2020200370."},{"title3":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]"},{"title3":"[Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing]"},{"title3":"Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patientsinfected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan,China: retrospective case series. BMJ 2020;368:m606."},{"title3":"Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study"},{"title3":"Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2"},{"title3":"Retrospective analysis of COVID-19 patients with different clinical subtypes"},{"title3":"Analysis of Chinese medical characteristics of 35 patients with novel coronavirus pneumonia"},{"title3":"Clinical features and ct signs of early family clustering novel coronavirus pneumonia"},{"title3":"Chest CT features of COVID 19"},{"title3":"CT features of patients with imported 2019-nCov-pneumonia"},{"title3":"Preliminary explore on ct characteristics of corona virus disease 2019 (COVID-19)"},{"title3":"The clinical features of the 143 patients with COVID-19 in north-east of Chongqing"},{"title3":"X F, Q M, T Y, et al. Clinical features and treatment analysis of 79 cases ofCOVID-19. Chinese pharmacological bulletin 2020:1-7."},{"title3":"Chest CT performance and clinical characteristics of corona virus disease 2019 (COVID-19)"},{"title3":"Analysis on chinese medical clinical characteristics of 50 patients with 2019-nCoV-infected pneumonia"},{"title3":"T. X, J. L, F. X, et al. Analysis of clinical characteristics of 49 patients with novel coronavirus pneumonia in Jiangxi province. Chinese J Resp Critical Care Med:1-7."},{"title3":"CT manifestations and dynamic changes of corona virus disease 2019"},{"title3":"Clinical characteristics and ct signs of corona virus disease 2019 (COVID-19) in the elderly"},{"title3":"Analysis of clinical characteristics of 25 patients with coronavirus disease in 2019"},{"title3":"Dynamic changes of chest ct imaging in patients with corona virus disease-19 (COVID-19)"},{"title3":"Analysis of Chinese medical characteristics of 88 patients with novel coronavirus pneumonia in Tianjin"},{"title3":"Clinical study on treatment of 34 cases of COVID-19 with combination of traditional Chinese and western medicine"},{"title3":"CT image features of asymptomatic patients with novel coronavirus"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in wuhan, china: a single-centered, retrospective, observational study"},{"title3":"Clinical presentations and ct features of imported corona virus disease 2019"},{"title3":"Analysis of the relationship between clinical features and tongue manifestations of 40 cases with novel coronavirus pneumonia"},{"title3":"A preliminary study on the clinical characteristics and Chinese medical syndrome of 42 cases of COVID-19 in Nanjing"},{"title3":"CT findings in 2019 novel coronavirus disease (COVID-19) patients"},{"title3":"Clinical and epidemiological characteristics of 26 patients diagnosed with novel coronavirus pneumonia"},{"title3":"The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration"},{"title3":"Meta-analysis of observational studies in epidemiology: a proposal for reporting"},{"title3":"American National Institute of Health. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools."},{"title3":"Meta-analysis of prevalence"},{"title3":"Measuring inconsistency in meta-analyses"},{"title3":"Bias in meta-analysis detected by a simple, graphical test"},{"title3":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated Sars pneumonia: a prospective study"},{"title3":"Hospital outbreak of middle east respiratory syndrome coronavirus"},{"title3":"Chen G., Wu D., Guo W., et al. Clinical and immunologic features in severe and moderate forms of coronavirus disease 2019. 2020:medRxiv2020.02.16.20023903."},{"title3":"Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients"},{"title3":"Novel coronavirus infection in hospitalized infants under 1 year of age in China"},{"title3":"The x chromosome and sex-specific effects in infectious disease susceptibility"}]},{"title2":"A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Viral metagenomics revealed Sendai virus and coronavirus infection of Malayan pangolins (Manis javanica)"},{"title3":"Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak"},{"title3":"On the origin and continuing evolution of SARS-CoV-2"},{"title3":"Conjunctival polymerase chain reaction-tests of 2019 novel coronavirus in patients in Shenyang, China"},{"title3":"Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient"},{"title3":"Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents"},{"title3":"Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination"},{"title3":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1"},{"title3":"Understanding the symptoms of the common cold and influenza"},{"title3":"Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19)"},{"title3":"Preliminary clinical description of severe acute respiratory syndrome"},{"title3":"MERS clinical features"},{"title3":"Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1)"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Novel coronavirus (COVID-19) situation"},{"title3":"Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China"},{"title3":"Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures"},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission"},{"title3":"Coronavirus COVID-19 global cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)"},{"title3":"Clinical management of severe acute respiratory infection when COVID-19 is suspected: interim guidance"},{"title3":"Evaluating and testing persons for coronavirus disease 2019 (COVID-19)"},{"title3":"Correlation of chest CT and RT-PCR testing in Coronavirus Disease 2019 (COVID-19) in China: a report of 1014 cases"},{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records"},{"title3":"Discharge criteria for confirmed COVID-19 cases - When is it safe to discharge COVID-19 cases from the hospital or end home isolation?"},{"title3":"Updated IPAC recommendations for use of personal protective equipment for care of individuals with suspect or confirmed COVID-19"},{"title3":"Beneficial effects of ascorbic acid to treat lung fibrosis induced by paraquat"},{"title3":"Neutrophil extracellular traps are elevated in patients with pneumonia-related acute respiratory distress syndrome"},{"title3":"The emerging role of vitamin C as a treatment for sepsis"},{"title3":"Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)"},{"title3":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19"},{"title3":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)"},{"title3":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors"},{"title3":"Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats"},{"title3":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker"},{"title3":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?"},{"title3":"Critically ill patients with the Middle East respiratory syndrome: a multicenter retrospective cohort study"}]},{"title2":"Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths","References":[{"title3":"Evidence that vitamin D supplementation could reduce risk of influenza and covid-19 infections and deaths"},{"title3":"Effect of vitamin D3 supplementation on respiratory tract infections in healthy individuals: A systematic review and meta-analysis of randomized controlled trials"},{"title3":"Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data"},{"title3":"Monthly high-dose vitamin D supplementation does not increase kidney stone risk or serum calcium: Results from a randomized controlled trial"},{"title3":"Effect of high-dose vitamin D supplementation on volumetric bone density and bone strength: a randomized clinical trial"},{"title3":"Clinical Trial [Trial No: IRCT20200324046850N1]"},{"title3":"Clnical Trial [Trial No: ChiCTR2000031163]"}]},{"title2":"Optimisation of Vitamin D Status for Enhanced Immuno-protection Against Covid-19","References":[]},{"title2":"Vitamin D, Covid-19 and Children","References":[{"title3":"A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19)"},{"title3":"Worldometer"},{"title3":"Epidemiology of COVID-19 among children in China"},{"title3":"COVID-19 in 17 Italian pediatric emergency departments"},{"title3":"Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections"},{"title3":"Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study"},{"title3":"Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials"},{"title3":"Modulation of the immune response to respiratory viruses by vitamin D"},{"title3":"Can vitamin D and L-cysteine co-supplementation reduce 25(OH)-Vitamin D Deficiency and the Mortality Associated with COVID-19 in African Americans?"},{"title3":"Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3"},{"title3":"Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26"},{"title3":"The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention"},{"title3":"The effect of vitamin D prophylaxis on 25-OH vitamin D levels in children"},{"title3":"Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths"},{"title3":"'Scientific Strabismus' or two related pandemics: coronavirus disease and vitamin D deficiency"},{"title3":"Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement"},{"title3":"Vitamin D deficiency in children and its management: review of current knowledge and recommendations"},{"title3":"Korelasyon ve Regresyon Analizi"},{"title3":"Vitamin D and respiratory tract infections in childhood"},{"title3":"Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis"},{"title3":"The prevalence of vitamin D deficiency among schoolchildren: a cohort study from Xinxiang, China"},{"title3":"Children with lower respiratory tract infections and serum 25-hydroxyvitamin D3 levels: a case-control study"},{"title3":"The association between vitamin D deficiency and community-acquired pneumonia: a meta-analysis of observational studies"},{"title3":"Link between community-acquired pneumonia and vitamin D levels in older patients Zusammenhang zwischen ambulant erworbener Pneumonie und vitamin-D-Spiegel bei alteren Patienten"},{"title3":"Study of IL-6 and vitamin D3 in patients of pulmonary tuberculosis"},{"title3":"Vitamin D deficiency is associated with IL-6 levels and monocyte activation in HIV-infected persons"},{"title3":"Serum 25-hydroxyvitamin d levels and C-reactive protein in persons with human immunodeficiency virus infection"},{"title3":"SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels"},{"title3":"The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality"},{"title3":"Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19"},{"title3":"Lessons learned from hereditary 1,25-dihydroxyvitamin D-resistant rickets patients on vitamin D functions"},{"title3":"COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis"},{"title3":"Clinical characteristics of 80 hospitalized frontline medical workers infected with COVID-19 in Wuhan, China"},{"title3":"Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019"},{"title3":"Vitamin D serum levels in patients with statin-induced musculoskeletal pain"},{"title3":"Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins"},{"title3":"Statin intolerance because of myalgia, myositis, myopathy, or myonecrosis can in most cases be safely resolved by vitamin D supplementation"},{"title3":"Association of vitamin D status and other clinical characteristics with COVID-19 test results"},{"title3":"Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study"},{"title3":"Is vitamin D deficiency a risk factor for COVID-19 in children?"},{"title3":"Vitamin D: the more we know, the less we know"}]},{"title2":"Letter: Covid-19, and vitamin D","References":[]},{"title2":"Randomized Trial of Vitamin D Supplementation to Prevent Seasonal Influenza and Upper Respiratory Infection in Patients With Inflammatory Bowel Disease","References":[{"title3":"Vitamin D deficiency"},{"title3":"Vitamin D deficiency and risk of cardiovascular disease"},{"title3":"25-hydroxyvitamin D levels and albuminuria in the third national health and nutrition examination survey (NHANES III)"},{"title3":"Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism"},{"title3":"Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease"},{"title3":"Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies"},{"title3":"Plasma 25-hydroxyvitamin D concentration and lymphoma risk: results of the European prospective investigation into cancer and nutrition"},{"title3":"Vitamin D and influenza"},{"title3":"Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y"},{"title3":"Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers"},{"title3":"Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren"},{"title3":"Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data"},{"title3":"Association between inflammatory bowel disease and vitamin D deficiency: a systematic review and meta-analysis"},{"title3":"Mechanisms of disease: vitamin D and inflammatory bowel disease"},{"title3":"Increased risk of pneumonia among patients with inflammatory bowel disease"},{"title3":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease"},{"title3":"Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease"},{"title3":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy"},{"title3":"Development of a Crohn's disease activity index. National cooperative Crohn's disease study"},{"title3":"Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer"},{"title3":"Vitamin D levels in adults with Crohn's disease are responsive to disease activity and treatment"},{"title3":"Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis"},{"title3":"Association of vitamin D level with clinical status in inflammatory bowel disease: a 5-year longitudinal study"},{"title3":"Immunomodulatory effects of vitamin D on innate and adaptive immune responses to streptococcus pneumoniae"},{"title3":"Modulation of the immune response to respiratory viruses by vitamin D"},{"title3":"Wintertime vitamin D supplementation inhibits seasonal variation of calcitropic hormones and maintains bone turnover in healthy men"},{"title3":"Vitamin D fortification as public health policy: significant improvement in vitamin D status in young finnish men"},{"title3":"Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young finnish men"}]}]},{"title1":"The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality","References":[{"title2":"Epidemic influenza and vitamin D","References":[]},{"title2":"Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data","References":[{"title3":"Department of Health. Department of Health Report on Health and Social Subjects, No. 49. Nutrition and bone health with particular reference to calcium and vitamin D. London; 1998."}]},{"title2":"Vitamin D and influenza-prevention or therapy?","References":[]},{"title2":"Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system","References":[{"title3":"Brain renin-angiotensin system in the nexus of hypertension and aging"},{"title3":"The renin angiotensin system and the brain: new developments"},{"title3":"Brain renin-angiotensin system and microglial polarization: implications for aging and neurodegeneration"},{"title3":"Protective axis of the renin-angiotensin system in the brain"},{"title3":"Mineralocorticoid receptor associates with pro-inflammatory bias in the hippocampus of spontaneously hypertensive rats"},{"title3":"Selective oestrogen receptor agonists rescued Hippocampus parameters in male spontaneously hypertensive rats"},{"title3":"Increased oxidative parameters and decreased cytokine levels in an animal model of attention-deficit/hyperactivity disorder"},{"title3":"Effects of diabetic hyperglycemia on central Ang-(1-7)-Mas-R-nNOS pathways in spontaneously hypertensive rats"},{"title3":"Induction of the vitamin D receptor attenuates autophagy dysfunction-mediated cell death following traumatic brain injury"},{"title3":"Stress and vitamin D: altered vitamin D metabolism in both the hippocampus and myocardium of chronic unpredictable mild stress exposed rats"},{"title3":"Vitamin D as a neurosteroid affecting the developing and adult brain"},{"title3":"Chronic stress causes neuroendocrine-immune disturbances without affecting renal vitamin D metabolism in rats"},{"title3":"Vitamin D receptor activation influences NADPH oxidase (NOX2) activity and protects against neurological deficits and apoptosis in a rat model of traumatic brain injury"},{"title3":"Vitamin D and cardiovascular disease prevention"},{"title3":"Chronic vitamin D deficiency induces lung fibrosis through activation of the renin-angiotensin system"},{"title3":"Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure"},{"title3":"Neurochemical effects of chronic administration of calcitriol in rats"},{"title3":"Regulatory mechanisms of vitamin D3 on production of nitric oxide and pro-inflammatory cytokines in microglial BV-2 cells"},{"title3":"AT2R activation prevents microglia pro-inflammatory activation in a NOX-dependent manner: inhibition of PKC activation and p47(phox) phosphorylation by PP2A"},{"title3":"Direct anti-inflammatory effects of angiotensin-(1-7) on microglia"},{"title3":"Vitamin D receptor activation influences the ERK pathway and protects against neurological deficits and neuronal death"},{"title3":"NOX activation by subunit interaction and underlying mechanisms in disease"},{"title3":"Nox family NADPH oxidases: molecular mechanisms of activation"},{"title3":"Angiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat primary astrocyte cultures"},{"title3":"Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors"},{"title3":"Spontaneously hypertensive rat as a model of vascular brain disorder: microanatomy, neurochemistry and behavior"},{"title3":"Protective effect of telmisartan against progressive oxidative brain damage and synuclein phosphorylation in stroke-resistant spontaneously hypertensive rats"},{"title3":"Dysregulation of vitamin D metabolism in the brain and myocardium of rats following prolonged exposure to dexamethasone"},{"title3":"The association between vitamin D binding protein polymorphisms and vitamin D level on epilepsy in China"},{"title3":"Vitamin D and the brain: genomic and non-genomic actions"},{"title3":"Vitamin D and cardiovascular disease: from atherosclerosis to myocardial infarction and stroke"},{"title3":"Vitamin D receptor-modulated Hsp70/AT1 expression may protect the kidneys of SHRs at the structural and functional levels"},{"title3":"Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress"},{"title3":"Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats"},{"title3":"Protective effect of calcitriol on podocytes in spontaneously hypertensive rat"},{"title3":"Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat"},{"title3":"Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats"},{"title3":"The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)"},{"title3":"Neuroprotection via AT2 receptor agonists in ischemic stroke"},{"title3":"Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors"},{"title3":"The heme oxygenase system selectively suppresses the proinflammatory macrophage m1 phenotype and potentiates insulin signaling in spontaneously hypertensive rats"},{"title3":"Systematic review and meta-analysis of the behavioral effects of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder"}]},{"title2":"Angiotensin-converting enzyme 2 in lung diseases","References":[{"title3":"A Novel Angiotensin-Converting Enzyme:Related to Angiotensin 1-9"},{"title3":"A human homolog of angiotensin-converting enzyme: Cloning and functional expression as a captopril-insensitive carboxypeptidase"},{"title3":"Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract"},{"title3":"Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme"},{"title3":"Trilogy of ACE2: A peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters"},{"title3":"The tissue renin-angiotensin system and intracellular signalling"},{"title3":"An Update on the Tissue Renin Angiotensin System and Its Role in Physiology and Pathology"},{"title3":"Revisiting the Brain Renin-Angiotensin System:Focus on Novel Therapies"},{"title3":"The ACE2/Angiotensin-(1-7)/Mas axis of the renin-angiotensin system: Focus on Angiotensin-(1-7)"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease"},{"title3":"The emerging role of ACE2 in physiology and disease"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney"},{"title3":"Losartan, a selective antagonist of AT1 receptor, attenuates seawater inhalation induced lung injury via modulating JAK2/STATs and apoptosis in rat"},{"title3":"Angiotensin II induces apoptosis in human and rat alveolar epithelial cells"},{"title3":"ACE-2/ANG1-7 ameliorates ER stress-induced apoptosis in seawater aspiration-induced acute lung injury"},{"title3":"Insulin regulates cytokines and intercellular adhesion molecule-1 gene expression through nuclear factor-kappaB activation in LPS-induced acute lung injury in rats"},{"title3":"Role of renin-angiotensin system in acute lung injury caused by viral infection"},{"title3":"The renin-angiotensin system: Going beyond the classical paradigms"},{"title3":"Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19"},{"title3":"Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factorkappaB and mitogen-activated protein kinases"},{"title3":"Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat"},{"title3":"Effect of chronic angiotensin converting enzyme inhibition on spatial memory and anxiety-like behaviours in rats"},{"title3":"Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies"},{"title3":"The renin-angiotensin-aldosterone system and the kidney: Effects on kidney disease"},{"title3":"Inflammatory responses and inflammation-associated diseases in organs"},{"title3":"Burying the dead: The impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease"},{"title3":"Autophagy and inflammation in chronic respiratory disease"},{"title3":"Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases"},{"title3":"Prevention of pulmonary hypertension by angiotensin-converting enzyme 2 gene transfer"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis"},{"title3":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections"},{"title3":"Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure"},{"title3":"The influence of angiotensin-(1-7) Mas receptor agonist (AVE 0991) on mitochondrial proteome in kidneys of apoE knockout mice"},{"title3":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction"},{"title3":"ACE2/Ang1-7 MAS AXIS: The counter-regulator of the classical renin angiotensin system"},{"title3":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: The GOLD science committee report 2019"},{"title3":"Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: A systematic analysis for the Global Burden of Disease Study"},{"title3":"An epidemiological study of the effects of statin use on airflow limitation in patients with chronic obstructive pulmonary disease"},{"title3":"Chronic obstructive pulmonary disease and comorbidities"},{"title3":"Mouse Mast Cell Protease-4 Deteriorates Renal Function by Contributing to Inflammation and Fibrosis in Immune Complex-Mediated Glomerulonephritis"},{"title3":"The systemic inflammation of alveolar hypoxia is initiated by alveolar macrophage-borne mediator(s)"},{"title3":"Effects of Angiotensin-Converting Enzyme Inhibitors on Spontaneous or Stimulated Generation of Reactive Oxygen Species by Bronchoalveolar Lavage Cells Harvested from Patients with or without Chronic Obstructive Pulmonary Disease"},{"title3":"Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease"},{"title3":"Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon"},{"title3":"Nicotine and the renin-angiotensin system"},{"title3":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016"},{"title3":"Physiologic similarities and differences between asthma and chronic obstructive pulmonary disease"},{"title3":"CD8+ T cells characterize early smoking-related airway pathology in patients with asthma"},{"title3":"Type 2 inflammation in asthma-present in most, absent in many"},{"title3":"Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells"},{"title3":"Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19"},{"title3":"COVID-19 and Asthma: Reflection During the Pandemic"},{"title3":"Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium"},{"title3":"Managing childhood allergies and immunodeficiencies during respiratory virus epidemics:The 2020 COVID-19 pandemic: A statement from the EAACI-section on pediatrics"},{"title3":"Asthma and COVID-19: Is asthma a risk factor for severe outcomes?"},{"title3":"Type 1 angiotensin II receptor antagonism reduces antigen-induced airway reactions"},{"title3":"Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation"},{"title3":"Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-kB-dependent pathways"},{"title3":"Severe exacerbations predict excess lung function decline in asthma"},{"title3":"Asthma: Clinical expression and molecular mechanisms"},{"title3":"COVID-19-related genes in sputum cells in asthma: Relationship to demographic features and corticosteroids"},{"title3":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension"},{"title3":"Epidemiology and treatment of pulmonary arterial hypertension"},{"title3":"Pathology and pathobiology of pulmonary hypertension: State of the art and research perspectives"},{"title3":"T-helper 17 cell polarization in pulmonary arterial hypertension"},{"title3":"The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series)"},{"title3":"Oral delivery of angiotensin-converting enzyme 2 and angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension"},{"title3":"Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/g-protein-coupled mas receptor axis attenuates pulmonary hypertension in ren-2 transgenic rats exposed to chronic hypoxia"},{"title3":"Activation of renin-angiotensin-aldosterone system (RAAS) in the lung of smoking-induced pulmonary arterial hypertension (PAH) rats"},{"title3":"ACE2 as therapy for pulmonary arterial hypertension: The good outweighs the bad"},{"title3":"AMP-activated protein kinase phosphorylation of angiotensin-converting enzyme 2 in endothelium mitigates pulmonary hypertension"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"A Novel Coronavirus from Patients with Pneumonia in China, 2019"},{"title3":"Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Clinical Characteristics of Coronavirus Disease 2019 in China"},{"title3":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia"},{"title3":"Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study"},{"title3":"Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus"},{"title3":"ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway"},{"title3":"Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information"},{"title3":"The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer"}]},{"title2":"Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society","References":[]},{"title2":"Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors","References":[]},{"title2":"Is vitamin D deficiency a major global public health problem?","References":[{"title3":"Vitamin D deficiency: a worldwide problem with health consequences"},{"title3":"IOF Committee of Scientific Advisors (CSA) Nutrition Working Group, Global vitamin D status and determinants of hypovitaminosis D"},{"title3":"Worldwide vitamin D status"},{"title3":"A global representation of vitamin D status in healthy populations"},{"title3":"25-hydroxyvitamin D levels among healthy children in Alaska"},{"title3":"Nutrition status in Argentinean children 6 to 72 months old: results from the National Nutrition and Health Survey (ENNyS)"},{"title3":"High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates"},{"title3":"Cross-sectional study of factors that influence the 25-hydroxyvitamin D status in pregnant women and in cord blood in Germany"},{"title3":"Vitamin D status indicators in indigenous populations in East Africa"},{"title3":"High prevalence of vitamin D deficiency among children aged 1 month to 16 years in Hangzhou, China"},{"title3":"Vitamin D status in pregnant Indian women across trimesters and different seasons and its correlation with neonatal serum 25-hydroxyvitamin D levels"},{"title3":"Vitamin D status in mothers and their newborns in Iran"},{"title3":"Vitamin D status of mothers and their neonates in Kuwait"},{"title3":"High prevalence of vitamin D deficiency in Pakistani mothers and their newborns"},{"title3":"Vitamin D deficiency in pregnant women and their neonates in spring time in western Turkey"},{"title3":"Vitamin D, PTH and calcium levels in pregnant women and their neonates"},{"title3":"Vitamin D concentrations among healthy children in Calgary, Alberta"},{"title3":"Vitamin D deficiency and anthropometric indicators of adiposity in school-age children: a prospective study"},{"title3":"Serum 25-hydroxyvitamin D levels among Mexican children ages 2 y to 12 y: a national survey"},{"title3":"Importance of Vitamin D: Role in Cardiovascular Disease and Status in Puerto Ricans"},{"title3":"Serum 25-hydroxyvitamin D concentrations and prevalence estimates of hypovitaminosis D in the U.S. population based on assay-adjusted data"},{"title3":"IDEFICS consortium, Determinants of vitamin D status in young children: results from the Belgian arm of the IDEFICS (Identification and Prevention of Dietary- and Lifestyle-Induced Health Effects in Children and Infants) Study"},{"title3":"Prevalence and predictors of vitamin D insufficiency in children: a Great Britain population based study"},{"title3":"Factors influencing the vitamin D status of 10-year-old urban South African children"},{"title3":"Vitamin D status of socio-economically deprived children in Kabul, Afghanistan"},{"title3":"Optimal vitamin A and suboptimal vitamin D status are common in Iranian infants"},{"title3":"Serum 25(OH)D concentrations in sunny Israel"},{"title3":"Vitamin D deficiency among healthy infants and toddlers: a prospective study from Irbid, Jordan"},{"title3":"High prevalence of vitamin D insufficiency and its association with BMI-for-age among primary school children in Kuala Lumpur, Malaysia"},{"title3":"Vitamin D deficiency in healthy children in a sunny country: associated factors"},{"title3":"Season and ethnicity are determinants of serum 25-hydroxyvitamin D concentrations in New Zealand children aged 5-14 y"},{"title3":"Vitamin D deficiency in girls from South Brazil: a cross-sectional study on prevalence and association with vitamin D receptor gene variants"},{"title3":"The vitamin D status of Canadians relative to the 2011 Dietary Reference Intakes: an examination in children and adults with and without supplement use"},{"title3":"Concentraciones sericas de vitamina D en ninos, adolescentes y adultos mexicanos"},{"title3":"HELENA Study Group, Vitamin D status among adolescents in Europe: the Healthy Lifestyle in Europe by Nutrition in Adolescence study"},{"title3":"Vitamin D status and its determinants in adolescents from the Northern Ireland Young Hearts 2000 cohort"},{"title3":"Vitamin D status of apparently healthy schoolgirls from two different socioeconomic strata in Delhi: relation to nutrition and lifestyle"},{"title3":"Vitamin D insufficiency among children and adolescents living in Tehran, Iran"},{"title3":"Vitamin D insufficiency in Korea--a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008"},{"title3":"Prevalence of vitamin D deficiency rickets in adolescent school girls in Western region, Saudi Arabia"},{"title3":"Vitamin D deficiency among healthy adolescents in Al Ain, United Arab Emirates"},{"title3":"Serum 25-hydroxyvitamin D concentrations of New Zealanders aged 15 years and older"},{"title3":"Vitamin D status in a sunny country: where has the sun gone?"},{"title3":"CaMos Research Group, 25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates"},{"title3":"High prevalence of vitamin D deficiency in Chilean healthy postmenopausal women with normal sun exposure: additional evidence for a worldwide concern"},{"title3":"Low vitamin D status despite abundant sun exposure"},{"title3":"Determinants of vitamin D status in a general population of Danish adults"},{"title3":"Seasonal variance of 25-(OH) vitamin D in the general population of Estonia, a Northern European country"},{"title3":"Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland"},{"title3":"Vitamin D status and health correlates among German adults"},{"title3":"Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors"},{"title3":"Cross-sectional and prospective cohort study of serum 25-hydroxyvitamin D level and obesity in adults: the HUNT study"},{"title3":"Diet, environmental factors, and lifestyle underlie the high prevalence of vitamin D deficiency in healthy adults in Scotland, and supplementation reduces the proportion that are severely deficient"},{"title3":"Vitamin D deficiency in Spain: a population-based cohort study"},{"title3":"Swiss Survey on Salt Group, Vitamin D levels and associated factors: a population-based study in Switzerland"},{"title3":"Vitamin D status of seminomadic Fulani men and women"},{"title3":"Hypovitaminosis D is common in both veiled and nonveiled Bangladeshi women"},{"title3":"Vitamin D status and metabolic syndrome in Asian Indians"},{"title3":"Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran"},{"title3":"Vitamin D status in Jordan: dress style and gender discrepancies"},{"title3":"Vitamin D and diabetes in Koreans: analyses based on the Fourth Korea National Health and Nutrition Examination Survey (KNHANES), 2008-2009"},{"title3":"High prevalence of vitamin D insufficiency and its association with obesity and metabolic syndrome among Malay adults in Kuala Lumpur, Malaysia"},{"title3":"Vitamin D levels in asymptomatic adults--a population survey in Karachi, Pakistan"},{"title3":"Vitamin D status in Sri Lankans living in Sri Lanka and Norway"},{"title3":"Regional variation and determinants of vitamin D status in sunshine-abundant Thailand"},{"title3":"Vitamin D status and parathyroid hormone in a urban population in Vietnam"},{"title3":"Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study"},{"title3":"Serum 25-hydroxyvitamin D concentration of Indigenous-Fijian and Fijian-Indian women"},{"title3":"Suboptimal vitamin D levels in pregnant women despite supplement use"},{"title3":"Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the United States"},{"title3":"High Prevalence of Vitamin D Deficiency in Pregnant Women: A National Cross-Sectional Survey"},{"title3":"Prenatal vitamin D status and risk of psychotic experiences at age 18years-a longitudinal birth cohort"},{"title3":"Maternal early-pregnancy vitamin D status is associated with maternal depressive symptoms in the Amsterdam Born Children and Their Development cohort"},{"title3":"SWS Study Group, Maternal vitamin D status in pregnancy is associated with adiposity in the offspring: findings from the Southampton Women's Survey"},{"title3":"INMA Project, Circulating 25-hydroxyvitamin D3 in pregnancy and infant neuropsychological development"},{"title3":"Vitamin D status of pregnant women in Shanghai, China"},{"title3":"Vitamin D status of pregnant and non-pregnant women of reproductive age living in Hanoi City and the Hai Duong province of Vietnam"},{"title3":"High prevalence of vitamin D insufficiency in healthy elderly people living at home in Argentina"},{"title3":"Influence of ultraviolet radiation on the production of 25 hydroxyvitamin D in the elderly population in the city of Sao Paulo (23 degrees 34'S), Brazil"},{"title3":"Vertebral fractures, osteoporosis and vitamin D levels in Chilean postmenopausal women"},{"title3":"Older Mayan residents of the western highlands of Guatemala lack sufficient levels of vitamin D"},{"title3":"Vitamin D status and falls, frailty, and fractures among postmenopausal Japanese women living in Hawaii"},{"title3":"Low prevalence of vitamin D deficiency in elderly Afro-Caribbean men"},{"title3":"Walk on the sunny side of life--epidemiology of hypovitaminosis D and mental health in elderly nursing home residents"},{"title3":"Associations between vitamin d and self-reported respiratory disease in older people from a nationally representative population survey"},{"title3":"Association of serum 25-hydroxyvitamin D with type 2 diabetes and markers of insulin resistance in a general older population in Finland"},{"title3":"Epidemic vitamin D deficiency among patients in an elderly care rehabilitation facility"},{"title3":"Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in healthy Hungarian men over 50 years of age: the HunMen Study"},{"title3":"Association between vitamin D status and physical performance: the InCHIANTI study"},{"title3":"Serum 25-hydroxyvitamin D levels and the metabolic syndrome in older persons: a population-based study"},{"title3":"Prevalence of low serum vitamin D concentration in an urban population of elderly women in Poland"},{"title3":"Association of low serum 25-hydroxyvitamin D levels and high arterial blood pressure in the elderly"},{"title3":"Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women"},{"title3":"Hypovitaminosis D and prevalent asymptomatic vertebral fractures in Moroccan postmenopausal women"},{"title3":"High prevalence of vitamin D insufficiency in China: relationship with the levels of parathyroid hormone and markers of bone turnover"},{"title3":"Vitamin D status in healthy Indians aged 50 years and above"},{"title3":"Vitamin D insufficiency among postmenopausal women in urban and rural areas in Guilan, Northern Iran"},{"title3":"Low serum 25-hydroxyvitamin D levels associated with falls among Japanese community-dwelling elderly"},{"title3":"Association between visceral obesity and sarcopenia and vitamin D deficiency in older Koreans: the Ansan Geriatric Study"},{"title3":"Vitamin D status among postmenopausal Malaysian women"},{"title3":"The prevalence of Vitamin D deficiency and effects of ultraviolet light on Vitamin D levels in elderly Turkish population"},{"title3":"Serum vitamin D and falls in older women in residential care in Australia"}]},{"title2":"Aging decreases the capacity of human skin to produce vitamin D3","References":[]},{"title2":"25-Hydroxy vitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density","References":[]},{"title2":"Racial pigmentation and the cutaneous synthesis of vitamin D","References":[]},{"title2":"Impaired bone marrow-derived macrophage differentiation in vitamin D deficiency","References":[]},{"title2":"1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation","References":[]},{"title2":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections","References":[{"title3":"Wild bird migration across the Qinghai-Tibetan plateau: a transmission route for highly pathogenic H5N1"},{"title3":"Highly pathogenic avian influenza (H5N1): pathways of exposure at the animal-human interface, a systematic review"},{"title3":"Qualitative and quantitative analyses of influenza virus receptors in trachea and lung tissues of humans, mice, chickens and ducks"},{"title3":"H5N1 Oseltamivir-resistance detection by real-time PCR using two high sensitivity labeled TaqMan probes"},{"title3":"Avian influenza: public health and food safety concerns"},{"title3":"The biochemistry of the renin-angiotensin system"},{"title3":"Peptidyl dipeptidase A: angiotensin I-converting enzyme"},{"title3":"Angiotensin-converting enzyme 2--a new cardiac regulator"},{"title3":"Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis"},{"title3":"Apelin is a positive regulator of ACE2 in failing hearts"},{"title3":"Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis"},{"title3":"ACE2: more of Ang-(1-7) or less Ang II?"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Human infection with highly pathogenic H5N1 influenza virus"},{"title3":"Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data"},{"title3":"Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China"},{"title3":"Avian influenza H5N1: an update on molecular pathogenesis"},{"title3":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury"},{"title3":"Inhibition of autophagy ameliorates acute lung injury caused by avian influenza A H5N1 infection"},{"title3":"Haunted with and hunting for viruses"},{"title3":"Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients"},{"title3":"The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome"},{"title3":"Physiology of local renin-angiotensin systems"},{"title3":"Angiotensin-converting enzyme 2 is an essential regulator of heart function"},{"title3":"Bench-to-bedside review: chest wall elastance in acute lung injury/acute respiratory distress syndrome patients"},{"title3":"Species-specific contribution of the four C-terminal amino acids of influenza A virus NS1 protein to virulence"},{"title3":"A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity"},{"title3":"Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control"},{"title3":"Heterologous interactions between NS1 proteins from different influenza A virus subtypes/strains"},{"title3":"Methionine-101 from one strain of H5N1 NS1 protein determines its IFN-antagonizing ability and subcellular distribution pattern"},{"title3":"Environmental connections of novel avian-origin H7N9 influenza virus infection and virus adaptation to the human"},{"title3":"Clinical findings in 111 cases of influenza A (H7N9) virus infection"},{"title3":"Lessons learnt from the human infections of avian-origin influenza A H7N9 virus: live free markets and human health"},{"title3":"The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis"},{"title3":"An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals"},{"title3":"Evidence for an intrinsic angiotensin system in the canine pancreas"}]},{"title2":"Age- and gender-related difference of ACE2 expression in rat lung [published correction appears in Life Sci 79:2499. Xudong, Xie [corrected to Xie, Xudong]; Junzhu, Chen [corrected to Chen, Junzhu]; Xingxiang, Wang [corrected to Wang, Xingxiang]; Furong, Zhang [corrected to Zhang, Furong]; Yanrong, Liu [corrected to Liu, Yanrong]]","References":[]}]}]}